Use

Oncology FISH Analysis – EGFR Amplification is a Fluorescence In Situ Hybridization (FISH) test designed to detect a common gene amplification in many different cancer types. The presence of EGFR amplification is generally associated with a poor prognosis but may predict response to various EGFR-targeted therapies. Results of this test must always be interpreted in the context of relevant clinical and pathological data and should not be used alone for a diagnosis of disease. Indications for Testing include patients with a clinical or suspected diagnosis of cancer and for inclusion in clinical trials.